Related Experiment Video
Updated: Jul 15, 2026
09:33
Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
Published on: March 20, 2026
Genomics and proteomics in neoplasia
1Department of Pathology, Stavanger University Hospital, Norway. baja@sus.no
Indian Journal of Pathology & Microbiology
|May 4, 2007
Summary
Genomics and proteomics offer valuable insights for cancer diagnosis and treatment. Rigorous validation and pathologist involvement are crucial for reliable molecular oncology services.
Area of Science:
- Oncology
- Genomics
- Proteomics
Background:
- Genomics and proteomics are increasingly vital in medical diagnostics, including cancer detection and treatment response prediction.
- Past disappointments highlight the need for rigorous validation of -omic tests.
- Molecular oncology services often lack pathologist integration, potentially limiting diagnostic accuracy.
Purpose of the Study:
- To emphasize the importance of independent validation for -omic tests in oncology.
- To advocate for the essential role of pathologists in molecular oncology services.
- To guide strategic decisions in selecting diseases and techniques for -omic analyses.
Main Methods:
- Review of current applications of genomics and proteomics in oncology.
- Discussion on the necessity of prospective validation studies.
- Highlighting the integration of pathological expertise with molecular techniques.
Main Results:
- -Omic tests require careful confirmation through independent prospective validation studies to prevent disappointments.
- Pathologist involvement is essential for optimal interpretation and application of molecular oncology data.
- Strategic selection of diseases and analytical techniques is critical for effective -omic analysis.
Conclusions:
- Pathologists must acquire expertise in -omic techniques and applications to enhance cancer diagnosis and treatment.
- Collaboration between pathologists and molecular scientists is key to advancing personalized oncology.
- Ensuring robust validation and expert interpretation maximizes the clinical utility of genomic and proteomic data.
More Related Videos
08:08Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
Published on: February 27, 2015
10:37Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification
Published on: November 15, 2017
Related Concept Videos
01:33Proteomics
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
02:02Genomics
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...